BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25696916)

  • 1. Hepatitis C virus-associated B-cell non-Hodgkin lymphomas.
    Vannata B; Zucca E
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):590-8. PubMed ID: 25696916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?
    Vannata B; Arcaini L; Zucca E
    Ther Adv Hematol; 2016 Apr; 7(2):94-107. PubMed ID: 27054025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
    Mihăilă RG
    World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
    Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
    J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and lymphoma.
    Paydas S
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
    Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas.
    Chindamo MC; Spector N; Segadas JA; Pimenta G; Vanderborght B; Morais JC; Milito C; Moraes Coelho HS
    Oncol Rep; 2002; 9(3):657-9. PubMed ID: 11956646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?
    Khoury T; Chen S; Adar T; Jacob EO; Mizrahi M
    World J Gastroenterol; 2014 Nov; 20(43):16197-202. PubMed ID: 25473174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of HCV induced B-cell clonal disorders.
    Landau DA; Saadoun D; Calabrese LH; Cacoub P
    Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas.
    Carloni G; Fioretti D; Rinaldi M; Ponzetto A
    Crit Rev Oncol Hematol; 2019 Jun; 138():156-171. PubMed ID: 31092372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis virus and malignant lymphoma].
    Iino S; Koike M
    Nihon Rinsho; 2000 Mar; 58(3):554-9. PubMed ID: 10741125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-Hodgkin's lymphoma and hepatitis C virus infection].
    Ennibi K; Bechade D; Rabhi M; Coutant G; Toloune F; Desrame J; Archane MI; Algayres JP
    Rev Med Interne; 2003 Jul; 24(7):452-8. PubMed ID: 12829218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature.
    Nooka A; Shenoy PJ; Sinha R; Lonial S; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):379-84. PubMed ID: 21729690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and lymphoma.
    Viswanatha DS; Dogan A
    J Clin Pathol; 2007 Dec; 60(12):1378-83. PubMed ID: 18042694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.
    Quinn ER; Chan CH; Hadlock KG; Foung SK; Flint M; Levy S
    Blood; 2001 Dec; 98(13):3745-9. PubMed ID: 11739181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
    Pozzato G; Mazzaro C; Gattei V
    Clin Liver Dis; 2017 Aug; 21(3):499-515. PubMed ID: 28689589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV-associated lymphomas.
    Fiorilli M; Mecucci C; Farci P; Casato M
    Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV infection and non-Hodgkin lymphomas: an evolving story.
    Defrancesco I; Zerbi C; Rattotti S; Merli M; Bruno R; Paulli M; Arcaini L
    Clin Exp Med; 2020 Aug; 20(3):321-328. PubMed ID: 32052244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
    Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
    JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.